TY - JOUR
T1 - Minimally Invasive Ponto Surgery Versus the Linear Incision Technique with Soft Tissue Preservation for Bone Conduction Hearing Implants
T2 - A Multicenter Randomized Controlled Trial
AU - Calon, Tim G.A.
AU - Johansson, Martin L.
AU - De Bruijn, Arthur J.G.
AU - Van Den Berge, Herbert
AU - Wagenaar, Mariet
AU - Eichhorn, Edwin
AU - Janssen, Miranda M.L.
AU - Hof, Janny R.
AU - Brunings, Jan Wouter
AU - Joore, Manuela A.
AU - Jonhede, Sofia
AU - Van Tongeren, Joost
AU - Holmberg, Marcus
AU - Stokroos, Robert Jan
N1 - Funding Information:
This study is sponsored by Oticon Medical AB (Askim, Sweden). The investigators had full access to all data. Monitoring was performed by the sponsor and TFS Develop (Zalt-bommel, The Netherlands). Data analysis was conducted by Statistiska Konsultgruppen (Gothenburg, Sweden).
Funding Information:
Sponsor details: Oticon Medical AB, Askim Sweden (Oticonmedical. com) This study is supported by a research grant from Oticon Medical AB (Askim, Sweden). T.C. is supported by a research grant from Oticon Medical AB (Askim, Sweden). M.L.J., S.J., and M.H. are paid employees of Oticon Medical. M.L.J. is supported by the research group of Professor P Thomsen (University of Gothenburg) and the resources provided by the Swedish Medical Research Council (K2015-52X-09495-28-4), ALFGBG-448851), the IngaBritt and Arne Lundberg Foundation and the Area of Advance Materials supported by the Swedish Government. Supplemental digital content is available in the text.
Publisher Copyright:
© 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of Otology & Neurotology, Inc.
PY - 2018/8/1
Y1 - 2018/8/1
N2 - Objective: To compare the surgical outcomes of the Minimally Invasive Ponto Surgery (MIPS) technique with those of the linear incision technique with soft-tissue preservation for bone-anchored hearing systems (BAHS). Design: Sponsor-initiated multicenter, open, randomized, controlled clinical trial. Setting: Maastricht University Medical Centre, Ziekenhuisgroep Twente and Medisch Centrum Leeuwarden, all situated in The Netherlands. Participants: Sixty-four adult patients eligible for unilateral BAHS surgery. Interventions Single-stage BAHS surgery with 1:1 randomization to the linear incision technique with soft-tissue preservation (control) or the MIPS (test) group. Primary and Secondary Outcome Measurements: Primary objective: compare the incidence of inflammation (Holgers Index ≥ 2) during 12 weeks' follow-up after surgery. Secondary objectives: skin dehiscence, pain scores, loss of sensibility around the implant, soft-tissue overgrowth, skin sagging, implant extrusion, cosmetic results, surgical time, wound healing and Implant Stability Quotient measurements. Results: Sixty-three subjects were analyzed in the intention-to-treat population. No significant difference was found for the incidence of inflammation between groups. Loss of skin sensibility, cosmetic outcomes, skin sagging, and surgical time were significantly better in the test group. No statistically significant differences were found for dehiscence, pain, and soft-tissue overgrowth. A nonsignificant difference in extrusion was found for the test group. The Implant Stability Quotient was statistically influenced by the surgical technique, abutment length, and time. Conclusion: No significant differences between the MIPS and the linear incision techniques were observed regarding skin inflammation. MIPS results in a statistically significant reduction in the loss of skin sensibility, less skin sagging, improved cosmetic results, and reduced surgical time. Although nonsignificant, the implant extrusion rate warrants further research.
AB - Objective: To compare the surgical outcomes of the Minimally Invasive Ponto Surgery (MIPS) technique with those of the linear incision technique with soft-tissue preservation for bone-anchored hearing systems (BAHS). Design: Sponsor-initiated multicenter, open, randomized, controlled clinical trial. Setting: Maastricht University Medical Centre, Ziekenhuisgroep Twente and Medisch Centrum Leeuwarden, all situated in The Netherlands. Participants: Sixty-four adult patients eligible for unilateral BAHS surgery. Interventions Single-stage BAHS surgery with 1:1 randomization to the linear incision technique with soft-tissue preservation (control) or the MIPS (test) group. Primary and Secondary Outcome Measurements: Primary objective: compare the incidence of inflammation (Holgers Index ≥ 2) during 12 weeks' follow-up after surgery. Secondary objectives: skin dehiscence, pain scores, loss of sensibility around the implant, soft-tissue overgrowth, skin sagging, implant extrusion, cosmetic results, surgical time, wound healing and Implant Stability Quotient measurements. Results: Sixty-three subjects were analyzed in the intention-to-treat population. No significant difference was found for the incidence of inflammation between groups. Loss of skin sensibility, cosmetic outcomes, skin sagging, and surgical time were significantly better in the test group. No statistically significant differences were found for dehiscence, pain, and soft-tissue overgrowth. A nonsignificant difference in extrusion was found for the test group. The Implant Stability Quotient was statistically influenced by the surgical technique, abutment length, and time. Conclusion: No significant differences between the MIPS and the linear incision techniques were observed regarding skin inflammation. MIPS results in a statistically significant reduction in the loss of skin sensibility, less skin sagging, improved cosmetic results, and reduced surgical time. Although nonsignificant, the implant extrusion rate warrants further research.
KW - Adolescent
KW - Adult
KW - Bone Conduction
KW - Cochlear Implantation/methods
KW - Cochlear Implants
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Minimally Invasive Surgical Procedures/methods
KW - Organ Sparing Treatments
KW - Postoperative Complications/epidemiology
KW - Suture Anchors
KW - Treatment Outcome
KW - Young Adult
UR - http://www.scopus.com/inward/record.url?scp=85050086555&partnerID=8YFLogxK
U2 - 10.1097/MAO.0000000000001852
DO - 10.1097/MAO.0000000000001852
M3 - Article
C2 - 29995008
AN - SCOPUS:85050086555
SN - 1531-7129
VL - 39
SP - 882
EP - 893
JO - Otology and Neurotology
JF - Otology and Neurotology
IS - 7
ER -